Suominen reports Q1 results on May 4. We expect the company to have managed a modest improvement but...
Scanfil’s Q1 was expected to be strong, however the results still clearly topped estimates by many p...
Redeye concludes that Q1 came in below its estimates, but where the qualitative TRaaS revenues were ...
Redeye concludes SSH Communications Q1’23 was weaker than expected due to customers’ hesitance to pl...
Redeye comments on GiG ahead of its Q1-results (due 4 May) where focus will be on the acquisition of...
Solid Q1, in line with consensus Strategic case remains unchanged after recent CMD No estimate chang...
Redeye comments on its estimates for Q1 2023, for which the Wireless segment is expected to be the m...
Redeye thinks the change of CFO appears to be a change of co-pilot from the CEO, rather than Martin ...
Partly driven by a strong start to 2023, with January revenue at EUR 5m, we expect another solid qua...
Agilyx published its 2022 results on 25 April, with the report highlighting significant demand momen...
Redeye looks positively upon today’s announcement that Genovis has acquired the patent rights to a u...
ChargePanel AB (publ) meddelade den 24 april att bolaget har ingått ett avtal för både ChargePanel E...
AAC Clyde Space (AAC) has reported very strong progression in Q123, in part due to booking deferred ...
CirChem har vunnit en upphandling och tecknat ramavtal med Gryaab för leverans av lösningsmedel.
Sales +16% y-o-y, -1% vs. ABGSCe EBIT SEK 54m, +2% vs.
Högre omsättning stärker marginalen CAG rapporterade under morgonen sin Q1-rapport.
Ideal partner inom transplantationsområdet Det exklusiva samarbets- och distributionsavtal med Therm...
Redeye provides a research update on Lipum following the Q1 report published by the company earlier ...
Redeye is encouraged to see Impact Coatings making further progress and executing on its expansion p...
Loihde reports its Q1 results on Friday, April 28th.
